phytic acid has been researched along with Leukemia in 2 studies
Phytic Acid: Complexing agent for removal of traces of heavy metal ions. It acts also as a hypocalcemic agent.
myo-inositol hexakisphosphate : A myo-inositol hexakisphosphate in which each hydroxy group of myo-inositol is monophosphorylated.
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grases, F | 1 |
| Simonet, BM | 1 |
| Vucenik, I | 1 |
| Perelló, J | 1 |
| Prieto, RM | 1 |
| Shamsuddin, AM | 1 |
| Deliliers, GL | 1 |
| Servida, F | 1 |
| Fracchiolla, NS | 1 |
| Ricci, C | 1 |
| Borsotti, C | 1 |
| Colombo, G | 1 |
| Soligo, D | 1 |
2 other studies available for phytic acid and Leukemia
| Article | Year |
|---|---|
Effects of exogenous inositol hexakisphosphate (InsP(6)) on the levels of InsP(6) and of inositol trisphosphate (InsP(3)) in malignant cells, tissues and biological fluids.
Topics: Animal Feed; Animals; Brain; Brain Chemistry; Breast Neoplasms; Chromatography, High Pressure Liquid | 2002 |
Effect of inositol hexaphosphate (IP(6)) on human normal and leukaemic haematopoietic cells.
Topics: Cell Cycle; Cell Death; Cell Division; DNA, Neoplasm; Dose-Response Relationship, Drug; Gene Express | 2002 |